Induction of antigen specific CD4+CD25+Foxp3+T regulatory cells from naïve natural thymic derived T regulatory cells

International Immunopharmacology

Volumn 28, Issue 2, 2015, Pages 875-886

  Hall, Bruce M ^a   Tran, Giang T ^a   Robinson, Catherine M ^a   Hodgkinson, Suzanne J ^a  

^a Liverpool Health Service   (Australia)

Author keywords

Antigen specific; CD4+CD25+Foxp3+T regulatory cells: Treg; Cytokines; IFN ; IL 12; IL 2; IL 4; IL 5; IL 5R; iTreg; Suppressor; Th1 like Treg; Th2 like; Tolerance; Treg; Ts1; Ts2; tTreg

Indexed keywords

CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 27; INTERLEUKIN 5 RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR T BET; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN;

ANTIGEN SPECIFICITY; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL LINEAGE; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; THYMOCYTE; ANIMAL; CYTOLOGY; IMMUNOLOGY; TH2 CELL; THYMUS;

ANIMALS; ANTIGENS, CD4; CYTOKINES; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH2 CELLS; THYMUS GLAND;

EID: 84948567319     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2015.03.049     Document Type: Article

References (217)

1. N. Seddiki, B. Santner-Nanan, J. Martinson, J. Zaunders, S. Sasson, A. Landay, and et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells J. Exp. Med. 203 7 2006 1693 1700
2. I. Horak Immunodeficiency in IL-2-knockout mice Clin. Immunol. Immunopathol. 76 3 pt2 1995 S172 S173
3. A.R. Almeida, N. Legrand, M. Papiernik, and A.A. Freitas Homeostasis of peripheral CD4 + T cells: IL-2R alpha and IL-2 shape a population of regulatory cells that controls CD4 + T cell numbers J. Immunol. 169 9 2002 4850 4860
4. E.A. Tivol, F. Borriello, A.N. Schweitzer, W.P. Lynch, J.A. Bluestone, and A.H. Sharpe Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4 Immunity 3 5 1995 541 547
5. J. Steiger, P.W. Nickerson, W. Steurer, M. Moscovitch-Lopatin, and T.B. Strom IL-2 knockout recipient mice reject islet cell allografts J. Immunol. 155 1 1995 489 498
6. R. Murray Physiologic roles of interleukin-2, interleukin-4, and interleukin-7 Curr. Opin. Hematol. 3 3 1996 230 234
7. P.A. Welch, A.E. Namen, R.G. Goodwin, R. Armitage, and M.D. Cooper Human IL-7: a novel T cell growth factor J. Immunol. 143 11 1989 3562 3567
8. A.M. Thornton, E.E. Donovan, C.A. Piccirillo, and E.M. Shevach Cutting edge: IL-2 is critically required for the in vitro activation of CD4 + CD25 + T cell suppressor function J. Immunol. 172 11 2004 6519 6523
9. M.K. Levings, R. Sangregorio, and M.G. Roncarolo Human CD4 + CD25 + T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function J. Exp. Med. 193 2001 1295 1302
10. P. Hoffmann, R. Eder, L.A. Kunz-Schughart, R. Andreesen, and M. Edinger Large-scale in vitro expansion of polyclonal human CD4(+)CD25 high regulatory T cells Blood 104 3 2004 895 903
11. Q. Tang, K.J. Henriksen, M. Bi, E.B. Finger, G. Szot, J. Ye, and et al. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes J. Exp. Med. 199 11 2004 1455 1465
12. K.L. Hippen, S.C. Merkel, D.K. Schirm, C. Nelson, N.C. Tennis, J.L. Riley, and et al. Generation and large-scale expansion of human inducible regulatory T cells that suppress graft-versus-host disease Am. J. Transplant. 11 2011 1148 1157 (Epub 2011 May 12)
13. K.E. Earle, Q. Tang, X. Zhou, W. Liu, S. Zhu, M.L. Bonyhadi, and et al. In vitro expanded human CD4 + CD25 + regulatory T cells suppress effector T cell proliferation Clin. Immunol. 115 2005 3 9
14. Q. Tang, J.A. Bluestone, and S.M. Kang CD4(+)Foxp3(+) regulatory T cell therapy in transplantation J. Mol. Cell Biol. 4 1 2012 11 21
15. C.G. Brunstein, J.S. Miller, Q. Cao, D.H. McKenna, K.L. Hippen, J. Curtsinger, and et al. Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics Blood 117 3 2011 1061 1070 (Epub 2010 Oct 15)
16. M. Di Ianni, F. Falzetti, A. Carotti, A. Terenzi, B. Del Papa, K. Perruccio, and et al. Immunoselection and clinical use of T regulatory cells in HLA-haploidentical stem cell transplantation Best Pract. Res. Clin. Haematol. 24 3 2011 459 466 (Epub 2011 Jun 29)
17. P. Trzonkowsk, M. Bieniaszewska, J. Juścińska, A. Dobyszuk, A. Krzystyniak, N. Marek, and et al. First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4 + CD25 + CD127 - T regulatory cells Clin. Immunol. 133 1 2009 22 26 (Epub 2009 Jun 25)
18. N. Marek-Trzonkowska, M. Myśliwiec, A. Dobyszuk, M. Grabowska, I. Derkowska, J. Juścińska, and et al. Therapy of type 1 diabetes with CD4(+)CD25(high)CD127-regulatory T cells prolongs survival of pancreatic islets - results of one year follow-up Clin. Immunol. 153 1 2014 23 30 10.1016/j.clim.2014.03.016 (Epub Apr 1)
19. E.K. Geissler, and J.A. Hutchinson Cell therapy as a strategy to minimize maintenance immunosuppression in solid organ transplant recipients Curr. Opin. Organ Transplant. 18 4 2013 408 415
20. Q. Tang, and K. Lee Regulatory T-cell therapy for transplantation: how many cells do we need? Curr. Opin. Organ Transplant. 17 4 2012 349 354
21. B.M. Hall Mechanisms maintaining enhancement of allografts. I. Demonstration of a specific suppressor cell J. Exp. Med. 161 1 1985 123 133
22. B.M. Hall, M.E. Jelbart, and S.E. Dorsch Suppressor T cells in rats with prolonged cardiac allograft survival after treatment with cyclosporine Transplantation 37 6 1984 595 600
23. B.M. Hall, M.E. Jelbart, and S.E. Dorsch Specific unresponsiveness to allografts induced by cyclosporine is not antibody dependent Transplant. Proc. 17 2 1985 1650 1652
24. B.M. Hall, M.E. Jelbart, K.E. Gurley, and S.E. Dorsch Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. Mediation of specific suppression by T helper/inducer cells J. Exp. Med. 162 5 1985 1683 1694
25. + suppressor cell and its mechanisms of action J. Exp. Med. 171 1 1990 141 157
26. + T cells J. Immunol. 143 2 1989 499 506
27. + suppressor cell on the presence of alloantigen and cytokines, including interleukin-2 Transplantation 55 2 1993 374 380
28. B.M. Hall, K.M. Plain, N.D. Verma, G. Tran, R. Boyd, C.M. Robinson, and et al. Transfer of allograft-specific tolerance requires CD4 + CD25 + T cells, but not IL-4 or TGF-β and cannot induce tolerance to linked antigens Transplantation 83 8 2007 1075 1084
29. S.C. Juvet, A.G. Whatcott, A.R. Bushell, and K.J. Wood Harnessing regulatory T cells for clinical use in transplantation: the end of the beginning Am. J. Transplant. 14 4 2014 750 763 10.1111/ajt.12647 (Epub 2014 Mar 4)
30. S.M. Kang, Q. Tang, and J.A. Bluestone CD4 + CD25 + regulatory T cells in transplantation: progress, challenges and prospects Am. J. Transplant. 7 6 2007 1457 1463
31. K.M. Plain, N.D. Verma, G.T. Tran, M. Nomura, R. Boyd, C.M. Robinson, and et al. Cytokines affecting CD4 + T regulatory cells in transplant tolerance. IV. Interleukin-4 does not maintain alloantigen specific CD4 + CD25 + Treg Transplant. Immunol. 29 2013 51 59 10.1016/j.trim.2013.10.003. Epub Oct 16
32. B.M. Hall, C.M. Robinson, K.M. Plain, N.D. Verma, N. Carter, R. Boyd, and et al. Studies on naïve CD4 + CD25 + T cells inhibition of naïve CD4 + CD25-T cells in mixed lymphocyte cultures Transpl. Immunol. 18 2008 291 300
33. S. Sakaguchi, M. Toda, M. Asano, M. Itoh, S.S. Morse, and N. Sakaguchi T cell-mediated maintenance of natural self-tolerance: its breakdown as a possible cause of various autoimmune diseases J. Autoimmun. 9 2 1996 211 220
34. S. Hori Lineage stability and phenotypic plasticity of Foxp3 + regulatory T cells Immunol. Rev. 259 2014 159 172
35. N. Ohkura, M. Hamaguchi, H. Morikawa, K. Sugimura, A. Tanaka, Y. Ito, and et al. T cell receptor stimulation-induced epigenetic changes and Foxp3 expression are independent and complementary events required for Treg cell development Immunity 37 5 2012 785 799 10.1016/j.immuni.2012.09.010 (Epub Nov 1)
36. S. Sakaguchi Regulatory T, cells: key controllers of immunologic self-tolerance Cell 101 5 2000 455 458
37. S. Sakaguchi Naturally arising Foxp3-expressing CD25 + CD4 + regulatory T cells in immunological tolerance to self and non-self Nat. Immunol. 6 4 2005 345 352
38. A.M. Thornton, and E.M. Shevach Suppressor effector function of CD4 + CD25 + immunoregulatory T cells is antigen nonspecific J. Immunol. 164 1 2000 183 190
39. C.A. Thornton, J.W. Upham, M.E. Wikstrom, B.J. Holt, G.P. White, M.J. Sharp, and et al. Functional maturation of CD4 + CD25 + CTLA4 + CD45RA + T regulatory cells in human neonatal T cell responses to environmental antigens/allergens J. Immunol. 173 5 2004 3084 3092
40. M. Nomura, K.M. Plain, N. Verma, C. Robinson, R. Boyd, S.J. Hodgkinson, and et al. The cellular basis of cardiac allograft rejection. IX. Ratio of naive CD4 + CD25 + T cells/CD4 + CD25 - T cells determines rejection or tolerance Transpl. Immunol. 15 4 2006 311 318
41. K.E. Webster, S. Walters, R.E. Kohler, T. Mrkvan, O. Boyman, C.D. Surh, and et al. In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression J. Exp. Med. 206 4 2009 751 760
42. M. Edinger, P. Hoffmann, J. Ermann, and et al. CD4 + CD25 + regulatory T cells preserve graft-versus-host activity while inhibiting graft-versus-host disease after bone morrow transplantation Nat. Med. 9 2003 1144 1150
43. P. Hoffmann, J. Ermann, M. Edinger, C.G. Fathman, and S. Strober Donor-type CD4 + CD25 + regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation J. Exp. Med. 196 3 2002 389 399
44. S. Sakaguchi Regulatory T, cells: history and perspective Methods Mol. Biol. 707 2011 3 17
45. Y. Bai, J. Liu, Y. Wang, and et al. l-selectin-dependent lymphoid occupancy is required to induce alloantigen-specific tolerance J. Immunol. 168 2002 1579
46. M.A. Schneider, J.G. Meingassner, M. Lipp, H.D. Moore, and A. Rot CCR7 is required for the in vivo function of CD4 + CD25 + regulatory T cells J. Exp. Med. 204 4 2007 735 745
47. P. Hoffmann, R. Eder, T.J. Boeld, K. Doser, B. Piseshka, R. Andreesen, and et al. Only the CD45RA + subpopulation of CD4 + CD25 high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion Blood 108 2006 4260 4267
48. B.M. Hall, G. Tran, and S.J. Hodgkinson Antigen specific T regulatory cells in transplant tolerance Int. Immunopharmacol. 9 2009 570 574
49. B.M. Hall, G.T. Tran, N.D. Verma, K.M. Plain, C.M. Robinson, M. Nomura, and et al. Do natural T regulatory cells become activated to antigen specific T regulatory cells in transplantation and in autoimmunity? Front. Immunol. 4 2013 208 10.3389/fimmu.2013.00208
50. B.M. Hall, N.D. Verma, G.T. Tran, and S.J. Hodgkinson Distinct regulatory CD4 + T cell subsets; differences between naïve and antigen specific T regulatory cells Curr. Opin. Immunol. 23 2011 1 7
51. K. Onodera, A. Chandraker, H.D. Volk, T. Ritter, M. Lehmann, H. Kato, and et al. Distinct tolerance pathways in sensitized allograft recipients after selective blockade of activation signal 1 or signal 2 Transplantation 68 2 1999 288 293
52. M.P. Wise, F. Bemelman, S.P. Cobbold, and H. Waldmann Linked suppression of skin graft rejection can operate through indirect recognition J. Immunol. 161 11 1998 5813 5816
53. A.O. Hall, D.P. Beiting, C. Tato, B. John, G. Oldenhove, C.G. Lombana, and et al. The cytokine interleukin-17 and interferon-g promote distinct Treg cell populations required to limit infection-induced pathology Immunity 37 23 2012 511 523
54. P. Sagoo, K. Ratnasothy, Y. Tsang, L.D. Barber, A. Noble, R.I. Lechler, and et al. Alloantigen-specific regulatory T cells prevent experimental chronic graft-versus-host disease by simultaneous control of allo- and autoreactivity Eur. J. Immunol. 42 12 2012 3322 3333
55. A. Trenado, M. Sudres, Q. Tang, S. Maury, F. Charlotte, S. Grégoire, and et al. Ex vivo-expanded CD4 + CD25 + immunoregulatory T cells prevent graft-versus-host-disease by inhibiting activation/differentiation of pathogenic T cells J. Immunol. 176 2006 1266 1273
56. J.L. Cohen, A. Trenado, D. Vasey, D. Klatzmann, and B.L. Salomon CD4(+)CD25(+) immunoregulatory T cells: new therapeutics for graft-versus-host disease J. Exp. Med. 196 3 2002 401 406
57. A. Trenado, S. Fisson, E. Braunberger, D. Klatzmann, B.L. Salomon, and J.L. Cohen Ex vivo selection of recipient-type alloantigen-specific CD4(+)CD25(+) immunoregulatory T cells for the control of graft-versus-host disease after allogeneic hematopoietic stem-cell transplantation Transplantation 77 1 Suppl. 2004 S32 S34
58. J.Y. Tsang, K. Ratnasothy, D. Li, Y. Chen, R.P. Bucy, K.F. Lau, and et al. The potency of allospecific Tregs cells appears to correlate with T cell receptor functional avidity Am. J. Transplant. 11 8 2011 1610 1620
59. W.F. Ng, P.J. Duggan, F. Ponchel, G. Matarese, G. Lombardi, A.D. Edwards, and et al. Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells Blood 98 9 2001 2736 2744
60. S. Jiang, N. Camara, G. Lombardi, and R.I. Lechler Induction of allopeptide-specific human CD4 + CD25 + regulatory T cells ex vivo Blood 102 6 2003 2180 2186
61. S. Jiang, D. Golshayan, J. Tsang, G. Lombardi, and R.I. Lechler In vitro expanded alloantigen-specific CD4 + CD25 + regulatory T cell treatment for the induction of donor-specific transplantation tolerance Int. Immunopharmacol. 6 2006 1879 1882
62. S. Jiang, J. Tsang, D.S. Game, S. Stevenson, G. Lombardi, and R.I. Lechler Generation and expansion of human CD4 + CD25 + regulatory T cells with indirect allospecificity: potential reagents to promote donor-specific transplantation tolerance Transplantation 82 2006 1738 1743
63. P. Sagoo, N. Ali, G. Garg, F.O. Nestle, R.I. Lechler, and G. Lombardi Human regulatory T cells with alloantigen specificity are more potent inhibitors of alloimmune skin graft damage than polyclonal regulatory T cells Sci. Transl. Med. 3 83 2011 83ra42
64. J. Hester, A. Schiopu, S.N. Nadig, and K.J. Wood Low-dose rapamycin treatment increases the ability of human regulatory T cells to inhibit transplant arteriosclerosis in vivo Am. J. Transplant. 12 8 2012 2008 2016
65. D.C. Wu, J. Hester, S.N. Nadig, W. Zhang, P. Trzonkowski, D. Gray, and et al. Ex vivo expanded human regulatory T cells can prolong survival of a human islet allograft in a humanized mouse model Transplantation 96 8 2013 707 716
66. J. Yates, F. Rovis, P. Mitchell, B. Afzali, J.Y. Tsang, M. Garin, and et al. The maintenance of human CD4 + CD25 + regulatory T cell function: IL-2, IL-4, IL-7 and IL-15 preserve optimal suppressive potency in vitro Int. Immunol. 19 6 2007 785 799 (Epub 2007 Jun 1)
67. P.Y. Mantel, and C.B. Schmidt-Weber Transforming growth factor-beta: recent advances on its role in immune tolerance Methods Mol. Biol. 677 2011 303 338 10.1007/978-1-60761-869-0-21
68. E.N. Huter, G.A. Punkosdy, D.D. Glass, L.I. Cheng, J.M. Ward, and E.M. Shevach TGF-beta-induced Foxp3 + regulatory T cells rescue scurfy mice Eur. J. Immunol. 38 7 2008 1814 1821
69. E.N. Huter, G.H. Stummvoll, R.J. DiPaolo, D.D. Glass, and E.M. Shevach Cutting edge: antigen-specific TGF beta-induced regulatory T cells suppress Th17-mediated autoimmune disease J. Immunol. 181 12 2008 8209 8213
70. L. Zhou, J.E. Lopes, M.M. Chong, I.I. Ivanov, R. Min, G.D. Victora, and et al. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function Nature 453 2008 236 240 (Epub 2008 Mar 26)
71. Q. Chen, Y.C. Kim, A. Laurence, G.A. Punkosdy, and E.M. Shevach IL-2 controls the stability of Foxp3 expression in TGF-{beta}-induced Foxp3 + T cells in vivo J. Immunol. 186 2011 6329 6337
72. E.M. Shevach, and A.M. Thornton tTregs, pTregs, and iTregs: similarities and differences Immunol. Rev. 259 1 2014 88 102 10.1111/imr.12160
73. C. Koenecke, N. Czeloth, A. Bubke, S. Schmitz, A. Kissenpfennig, B. Malissen, and et al. Alloantigen-specific de novo-induced Foxp3 + Treg revert in vivo and do not protect from experimental GVHD Eur. J. Immunol. 39 2009 3091 3096
74. S. Sakaguchi, D.A.A. Vignali, A.Y. Rudensky, R.E. Niec, and H. Waldmann The plasticity and stability of regulatory T cells Nat. Rev. Immunol. 13 6 2013 461 467
75. B. Afzali, P. Mitchell, R.I. Lechler, S. John, and G. Lombardi Translational mini-review series on Th17 cells: induction of interleukin-17 production by regulatory T cells Clin. Exp. Immunol. 159 2 2010 120 130 (Epub 2009 Nov 11. Review)
76. J. Huehn, J.K. Polansky, and A. Hamann Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage? Nat. Rev. Immunol. 9 2009 83 89
77. R.S. Francis, G. Feng, T. Tha-In, I.S. Lyons, K.J. Wood, and A. Bushell Induction of transplantation tolerance converts potential effector T cells into graft-protective regulatory T cells Eur. J. Immunol. 41 2011 726 738
78. M. Karim, C.I. Kingsley, A.R. Bushell, B.S. Sawitzki, and K.J. Wood Alloantigen-induced CD25 + CD4 + regulatory T cells can develop in vivo from CD25-CD4 + precursors in a thymus-independent process J. Immunol. 172 2 2004 923 928
79. A.R. Kendal, Y. Chen, F.S. Regateiro, J. Ma, E. Adams, S.P. Cobbold, and et al. Sustained suppression by Foxp3 + regulatory T cells is vital for infectious transplantation tolerance J. Exp. Med. 208 10 2011 2043 2053 10.1084/jem.20110767 (Epub 2011 Aug 29)
80. M. Miyara, Y. Yoshioka, A. Kitoh, T. Shima, K. Wing, A. Niwa, and et al. Functional delineation and differentiation dynamics of human CD4 + T cells expressing the FoxP3 transcription factor Immunity 30 6 2009 899 911
81. S. Sakaguchi, M. Miyara, C.M. Costantino, and D.A. Hafler FOXP3 + regulatory T cells in the human immune system Nat. Rev. Immunol. 10 7 2010 490 500
82. D.J. Campbell, and M.A. Koch Phenotypical and functional specialization of FOXP3 + regulatory T cells Nat. Rev. Immunol. 11 2011 119 130
83. H.W. Lim, J.J. Lee, P. Hillsamer, and C.H. Kim Human Th17 cells share major trafficking receptors with both polarized effector T cells and FOXP3 + regulatory T cells J. Immunol. 180 2008 122 129
84. N.D. Verma, K.M. Plain, M. Nomura, G.T. Tran, C.M. Robinson, R. Boyd, and et al. CD4 + CD25 + T cells alloactivated ex vivo by IL-2 or IL-4, become potent alloantigen specific inhibitors of rejection with different phenotypes, suggesting Th1 and Th2 responses activate by separate pathways Blood 113 2009 479 487
85. B. Afzali, P.J. Mitchell, F.C. Edozie, G.A. Povoleri, S.E. Dowson, L. Demandt, and et al. CD161 expression characterizes a subpopulation of human regulatory T cells that produces IL-17 in a STAT3-dependent manner Eur. J. Immunol. 43 8 2013 2043 2054
86. A. Chaudhry, D. Rudra, P. Treuting, R.M. Samstein, Y. Liang, A. Kas, and et al. CD4 + regulatory T cells control TH17 responses in a Stat3-dependent manner Science 326 2009 986 991
87. P.T. Sage, A.M. Paterson, S.B. Lovitch, and A.H. Sharpe The coinhibitory receptor CTLA-4 controls B cell responses by modulating T follicular helper, T follicular regulatory, and T regulatory cells Immunity 41 6 2014 1026 1039
88. M. Esposito, F. Ruffini, A. Bergami, L. Garzetti, G. Borsellino, L. Battistini, and et al. IL-17- and IFNg-secreting Foxp3 + T cells infiltrate target tissue in experimental autoimmunity J. Immunol. 185 2010 7467 7473
89. M.A. Koch, K.R. Thomas, N.R. Perdue, K.S. Smigiel, S. Srivastava, and D.J. Campbell T-bet(+) Treg cells undergo abortive Th1 cell differentiation due to impaired expression of IL-12 receptor β2 Immunity 37 3 2012 501 510 10.1016/j.immuni.2012.05.031. Epub Sep 6
90. M.A. Koch, G. Tucker-Heard, N.R. Perdue, J.R. Killebrew, K.B. Urdahl, and D.J. Campbell The transcription factor T-bet controls regulatory T cell homeostasis and function during type-1 inflammation Nat. Immunol. 10 2009 595 602
91. P. Stock, O. Akbari, G. Berry, G.J. Freeman, R.H. Dekruyff, and D.T. Umetsu Induction of T helper type 1-like regulatory cells that express Foxp3 and protect against airway hyper-reactivity Nat. Immunol. 5 11 2004 1149 1156 (Epub 2004 Sep 26)
92. Y. Zheng, A. Chaudhry, A. Kas, P. deRoos, J.M. Kim, T.-T. Chu, and et al. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control TH2 responses Nature 458 March 19 2009 351 356 10.1038/nature07674
93. A. Veerapathran, J. Pidala, F. Beato, X.Z. Yu, and C. Anasetti Ex vivo expansion of human Tregs specific for alloantigens presented directly or indirectly Blood 118 20 2011 5671 5680 (Epub 2011 Sep 23)
94. J.H. Peters, L.B. Hilbrands, H.J. Koenen, and I. Joosten Ex vivo generation of human alloantigen-specific regulatory T cells from CD4(pos)CD25(high) T cells for immunotherapy PLoS One 3 5 2008 e2233
95. G.T. Tran, S.J. Hodgkinson, N.M. Carter, N.D. Verma, K.M. Plain, R. Boyd, and et al. Interleukin-5 (IL-5) promotes induction of antigen specific CD4 + CD25 + T regulatory cells that suppress autoimmunity Blood 119 2012 4441 4450 (E pub Feb 6 2012)
96. L.C. Chen, J.C. Delgado, P.E. Jensen, and X. Chen Direct expansion of human allospecific FoxP3 + CD4 + regulatory T cells with allogeneic B cells for therapeutic application J. Immunol. 183 6 2009 4094 4102 (Epub 2009 Aug 14)
97. A.L. Putnam, N. Safinia, A. Medvec, M. Laszkowska, M. Wray, M.A. Mintz, and et al. Clinical grade manufacturing of human alloantigen-reactive regulatory T cells for use in transplantation Am. J. Transplant. 13 11 2013 3010 3020
98. M. Battaglia, A. Stabilini, B. Migliavacca, J. Horejs-Hoeck, T. Kaupper, and M.G. Roncarolo Rapamycin promotes expansion of functional CD4 + CD25 + FOXP3 + regulatory T cells of both healthy subjects and type 1 diabetic patients J. Immunol. 177 12 2006 8338 8347
99. M. Battaglia, A. Stabilini, and M.G. Roncarolo Rapamycin selectively expands CD4 + CD25 + FoxP3 + regulatory T cell Blood 105 2005 4743 4748
100. A.L. Putnam, T.M. Brusko, M.R. Lee, W. Liu, G.L. Szot, T. Ghosh, and et al. Expansion of human regulatory T-cells from patients with type 1 diabetes Diabetes 58 3 2009 652 662
101. C. Peter, H. Waldmann, and S.P. Cobbold mTOr signalling and metabolic regulation of T cell differentiation Curr. Opin. Immunol. 22 5 2010 655 661
102. C. Scottà, M. Esposito, H. Fazekasova, G. Fanelli, F.C. Edozie, N. Ali, and et al. Differential effects of rapamycin and retinoic acid on expansion, stability and suppressive qualities of human CD4(+)CD25(+)FOXP3(+) T regulatory cell subpopulations Haematologica 98 8 2013 1291 1299
103. M. Carvalho-Gaspar, N.D. Jones, S. Luo, L. Martin, M.O. Brook, and K.J. Wood Location and time-dependent control of rejection by regulatory T cells culminates in a failure to generate memory T cells J. Immunol. 180 10 2008 6640 6648
104. N.D. Verma, B.M. Hall, K.M. Plain, C.M. Robinson, R. Boyd, G.T. Tran, and et al. Interleukin-12 (IL-12p70) promotes induction of highly potent Th1-like CD4(+)CD25(+) T regulatory cells that inhibit allograft rejection in unmodified recipients Front. Immunol. 9 2014 190 10.3389/fimmu.2014.00190
105. H. Groux Type 1 T-regulatory cells: their role in the control of immune responses Transplantation 75 9 Suppl. 2003 8S 12S
106. M. Sykes, D.A. Pearson, P.A. Taylor, G.L. Szot, S.J. Goldman, and B.R. Blazar Dose and timing of interleukin (IL)-12 and timing and type of total-body irradiation: effects on graft-vs.-host disease inhibition and toxicity of exogenous IL-12 in murine bone marrow transplant recipients Biol. Blood Marrow Transplant. 5 1999 277 284
107. N.D. Verma, R. Boyd, C. Robinson, K.M. Plain, G.T. Tran, and B.M. Hall Interleukin-12p70 prolongs allograft survival by induction of interferon gamma and nitric oxide production Transplantation 82 10 2006 1324 1333
108. T.K. Tarrant, P.B. Silver, J.L. Wahlstern, L.V. Rizzo, C.C. Chan, B. Wiggert, and et al. Interleukin 12 protects from a T helper 1-mediated autoimmune disease, experimental autimmune uveitis, through a mechanism involving interferon gamma, nitric oxide and apoptosis J. Exp. Med. 189 1999 219
109. G. Oldenhove, N. Bouladoux, E.A. Wohlfert, J.A. Hall, D. Chou, L. Dos Santos, and et al. Decrease of Foxp3 + Treg cell number and acquisition of effector cell phenotype during lethal infection Immunity 31 2009 772 786
110. J. Zhao, T. Zhang, H. He, and Y. Xie Interleukin-2 inhibits polarization to T helper type 1 cells and prevents mouse acute graft-versus-host disease through up-regulating suppressors of cytokine signalling-3 expression of naive CD4 T cells Clin. Exp. Immunol. 160 2010 479 488 (Epub 2010 Feb 2)
111. Z. Zhao, S. Yu, D.C. Fitzgerald, M. Elbehi, B. Ciric, A.M. Rostami, and et al. IL-12R beta 2 promotes the development of CD4 + CD25 + regulatory T cells J. Immunol. 181 6 2008 3870 3876
112. J. Zhao, J. Zhao, and S. Perlman Differential effects of IL-12 on Tregs and non-Treg T cells: roles of IFN-γ, IL-2 and IL-2R PLoS One 7 9 2012 e46241
113. T. Feng, A.T. Cao, C.T. Weaver, C.O. Elson, and Y. Cong Interleukin-12 converts Foxp3 + regulatory T cells to interferon-γ-producing Foxp3 + T cells that inhibit colitis Gastroenterology 140 7 2011 2031 2043 10.1053/j.gastro.2011.03.009 (Epub Mar 17)
114. K.J. Wood, G. Feng, B. Wei, B. Sawitzki, and A.R. Bushell Interferon gamma: friend or foe? Transplantation 84 2007 S4 S5
115. L.G. Hidalgo, and P.F. Halloran Role of IFN-gamma in allograft rejection Crit. Rev. Immunol. 22 4 2002 317 349
116. V. Daniel, M. Sadeghi, H. Wang, and G. Opelz CD4(+)CD25(+)Foxp3(+)IFN-γ(+) human induced T regulatory cells are induced by interferon-γ and suppress alloresponses nonspecifically Hum. Immunol. 72 9 2011 699 707
117. H. Nishikawa, T. Kato, I. Tawara, H. Ikeda, K. Kuribayashi, P.M. Allen, and et al. IFN-γ controls the generation/activation of CD4 + CD25 + regulatory T cells in antitumor immune response J. Immunol. 175 2005 4433 4440
118. G. Feng, K.J. Wood, and A. Bushell Interferon-gamma conditioning ex vivo generates CD25 + CD62L + Foxp3 + regulatory T cells that prevent allograft rejection: potential avenues for cellular therapy Transplantation 86 2008 578 589
119. Z.J.H. Wang, J. Hong, W. Sun, G. Xu, N. Li, X. Chen, and et al. Role of IFN-g in induction of Foxp3 and conversion of CD4 + CD25- T cells to CD4 + Tregs J. Clin. Invest. 116 2006 2434 2441
120. T. Nishibori, Y. Tanabe, L. Su, and M. David Impaired development of CD4 + CD25 + regulatory T cells in the absence of STAT1: increased susceptibility to autoimmune disease J. Exp. Med. 199 1 2004 25 34
121. B. Wei, S. Baker, J. Wieckiewicz, and K.J. Wood IFN-gamma triggered STAT1-PKB/AKT signalling pathway influences the function of alloantigen reactive regulatory T cells Am. J. Transplant. 10 1 2010 69 80 (Epub 2009 Nov 4)
122. G. Feng, T. Chan, K.J. Wood, and A. Bushell Donor reactive regulatory T cells Curr. Opin. Organ Transplant. 14 2009 69 80
123. G. Feng, W. Gao, T.B. Strom, M. Oukka, R.S. Francis, K.J. Wood, and et al. Exogenous IFN-gamma ex vivo shapes the alloreactive T-cell repertoire by inhibition of Th17 responses and generation of functional Foxp3 + regulatory T cells Eur. J. Immunol. 38 9 2008 2512 2527
124. G. Feng, K.J. Wood, and A. Bushell Regulatory T cell enrichment by IFN-g conditioning Methods Mol. Biol. 677 2011 281 301
125. G. Warnecke, G. Feng, R. Goto, S.N. Nadig, R. Francis, K.J. Wood, and et al. CD4 + regulatory T cells generated in vitro with IFN-{gamma} and allogeneic APC inhibit transplant arteriosclerosis Am. J. Pathol. 177 1 2010 464 472
126. G. Tellides, and J.S. Pober Interferon-g axis in graft atherosclerosis Circ. Res. 100 2007 622 632
127. M. Hart-Matyas, S. Nejat, J.L. Jordan, G.M. Hirsch, and T.D.J. Lee IFN-g and Fas/FasL pathways cooperate to induce medial cell loss and neointimal lesion formation in allograft vasculopathy Transplant. Immunol. 22 2010 157 164
128. V. Daniel, M. Sadeghi, H. Wang, and G. Opelz CD4(+)CD25(+)Foxp3(+)IFNγ(+) Treg are immunosuppressive in vitro and increase with intensity of the alloresponse in pretransplant MLC Transpl. Immunol. 27 3 2012 114 121 10.1016/j.trim.2012.08.003 (Epub Aug 27)
129. Z. Wang, J. Hong, W. Sun, G. Xu, N. Li, X. Chen, and et al. Role of IFN-gamma in induction of Foxp3 and conversion of CD4 + CD25- T cells to CD4 + Tregs J. Clin. Invest. 116 9 2006 2434 2441
130. D. Stroopinsky, I. Avivi, J.M. Rowe, D. Avigan, and T. Katz Allogeneic induced human FOXP3(+)IFN-gamma(+) T cells exhibit selective suppressive capacity Eur. J. Immunol. 39 2009 2703 2715
131. M. Dominguez-Villar, C.M. Baecher-Allan, and D.A. Hafler Identification of T helper type 1-like, Foxp3(+) regulatory T cells in human autoimmune disease Nat. Med. 17 2011 673 675
132. A. Hoerning, K. Koss, D. Datta, L. Boneschansker, C.N. Jones, I.Y. Wong, and et al. Subsets of human CD4(+) regulatory T cells express the peripheral homing receptor CXCR3 Eur. J. Immunol. 41 8 2011 2291 2302 10.1002/eji.201041095 (Epub 2011 Jun 24)
133. V. Daniel, C. Naujokat, M. Sadeghi, R. Weimer, F. Renner, S. Yildiz, and et al. Observational support for an immunoregulatory role of CD3 + CD4 + CD25 + IFN-gamma + blood lymphocytes in kidney transplant recipients with good long-term graft outcome Transpl. Int. 21 7 2008 646 660 10.1111/j.432-2277.008.00662.x (Epub 2008 Feb 20)
134. V. Daniel, M. Sadeghi, H. Wang, and G. Opelz CD4(+)CD25(+)Foxp3(+)IFNγ(+)CD178(+) human induced Treg (iTreg) contribute to suppression of alloresponses by apoptosis of responder cells Hum. Immunol. 74 2 2013 151 162 10.1016/j.humimm.2012.09.010 Epub Sep 24()
135. J.M. Laurence, C. Wang, E.T. Park, A. Buchanan, A. Clouston, R.D. Allen, and et al. Blocking indoleamine dioxygenase activity early after rat liver transplantation prevents long-term survival but does not cause acute rejection Transplantation 85 9 2008 1357 1361
136. G. Oldenhove, M. de Heusch, G. Urbain-Vansanten, J. Urbain, C. Maliszewski, O. Leo, and et al. CD4 + CD25 + regulatory T cells control T helper cell type 1 responses to foreign antigens induced by mature dendritic cells in vivo J. Exp. Med. 198 2 2003 259 266
137. C. Guillonneau, M. Hill, F.X. Hubert, E. Chiffoleau, C. Hervé, X.L. Li, and et al. CD40Ig treatment results in allograft acceptance mediated by CD8CD45RC T cells, IFN-gamma, and indoleamine 2,3-dioxygenase J. Clin. Invest. 117 4 2007 1096 1106
138. K. Kishimoto, S. Sandner, J. Imitola, M. Sho, Y. Li, P.B. Langmuir, and et al. Th1 cytokines, programmed cell death, and alloreactive T cell clone size in transplant tolerance J. Clin. Invest. 109 11 2002 1471 1479
139. M.R. Nicolls, M. Coulombe, A.S. Diamond, J. Beilke, and R.G. Gill Interferon-g is not a universal requirement for islet allograft survival Transplantation 74 2002 472 477
140. M.R. Nicolls, M. Coulombe, A. Yang, A. Bolwerk, and R.G. Gill Anti-LFA 1 therapy induces long-term islet allograft acceptance in the absence of IFN-gamma or IL-4 J. Immunol. 164 7 2000 3627 3634
141. B. Sawitzki, C.I. Kingsley, V. Oliveira, M. Karim, M. Herber, and K.J. Wood IFN-gamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo J. Exp. Med. 201 12 2005 1925 1935
142. B. Sawitzki, M. Lehmann, R.E. Graser, J.W. Kupiec-Weglinski, and H.D. Volk Regulatory tolerance-mediating T cells in transplantation tolerance Transplant. Proc. 33 2001 2092 2093
143. C.Q. Chu, S. Wittmer, and D.K. Dalton Failure to suppress the expansion of the activated CD4 T cell population in interferon-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis J. Exp. Med. 192 2000 117 122
144. B.T. Konieczny, Z. Dai, E.T. Elwood, S. Saleem, P.S. Linsley, F.K. Baddoura, and et al. IFN-gamma is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways J. Immunol. 160 5 1998 2059 2064
145. Z. Dai, B.T. Konieczny, F.K. Baddoura, and F.G. Lakkis Impaired alloantigen-mediated T cell apoptosis and failure to induce long-term allograft survival in IL-2-deficient mice J. Immunol. 161 4 1998 1659 1663
146. T.S. Mele, N.M. Kneteman, L.F. Zhu, V. Ramassar, J. Urmson, and et al. IFN-gamma is an absolute requirement for spontaneous acceptance of liver allografts Am. J. Tranplant. 3 2003 942 951
147. A.D. Wells, X.C. Li, Y. Li, M.C. Walsh, X.X. Zheng, Z. Wu, and et al. Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance Nat. Med. 5 11 1999 1303 1307
148. X.C. Li, A.D. Wells, T.B. Strom, and L.A. Turka The role of T cell apoptosis in transplantation tolerance Curr. Opin. Immunol. 12 5 2000 522 527
149. A.R. Kitching, A.L. Turner, T. Semple, M. Li, K.L. Edgtton, G.R. Wilson, and et al. Experimental autoimmune anti-glomerular basement membrane glomerulonephritis: a protective role for IFN-gamma J. Am. Soc. Nephrol. 15 7 2004 1764 1774
150. D.O. Willenborg, and et al. Interferon-gamma is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue; a possible role for nitric oxide J. Immunol. 163 1999 5278 5286
151. H. Kelchtermans, B. De Klerck, T. Mitera, and et al. Defective CD4 + CD25 + regulatory T cell function in collagen-induced arthritis: an important factor in pathogenesis Arthritis Res. Ther. 7 2005 R401
152. G.A. Bishop, A.F. Dharland, and G.W. McCaughan High-dose/activation-associated tolerance model for allografts: lessons from spontaneous tolerance of transplanted livers Curr. Opin. Organ Transplant. 4 1 1999 58 64
153. H. Nagano, P. Libby, M.K. Taylor, S. Hasegawa, J.L. Stinn, G. Becker, and et al. Coronary arteriosclerosis after T-cell-mediated injury in transplanted mouse hearts: role of interferon-gamma Am. J. Pathol. 152 5 1998 1187 1197
154. M. Miura, T. El-Sawy, and R.L. Fairchild Neutrophils mediate parenchymal tissue necrosis and accelerate the rejection of complete major histocompatibility complex-disparate cardiac allografts in the absence of interferon-gamma Am. J. Pathol. 162 2 2003 509 519
155. B.T. Konieczny, Z. Dai, E.T. Elwood, and et al. IFN-g is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways J. Immunol. 160 1998 2059 2064
156. S.L. Swain T-cell subsets. Who does the polarizing? Curr. Biol. 5 8 1995 849 851
157. L.G. Hidalgo, J. Urmson, and P.F. Halloran IFN-gamma decreases CTL generation by limiting IL-2 production: A feedback loop controlling effector cell production Am. J. Transplant. 5 4 Pt 1 2005 651 661
158. D.K. Dalton, L. Haynes, C.Q. Chu, S.L. Swain, and S. Wittmer Interferon gamma eliminates responding CD4 T cells during mycobacterial infection by inducing apoptosis of activated CD4 T cells J. Exp. Med. 192 2000 117 122
159. R.A. Seder, and R. Ahmed Similarities and differences in CD4 + and CD8 + effector and memory T cell generation Nat. Immunol. 4 9 2003 835 842
160. V.P. Badovinac, S.E. Hamilton, and J.T. Harty Viral infection results in massive CD8 + T cell expansion and mortality in vaccinated perforin-deficient mice Immunity 18 4 2003 463 474
161. V.P. Badovinac, A.R. Tvinnereim, and J.T. Harty Regulation of antigen-specific CD8 + T cell homeostasis by perforin and IFN-gamma Science 290 2000 1354 1358
162. Y. Liu, and C.A. Janeway Jr. Interferon gamma plays a critical role in induced cell death of effector T cell: a possible third mechanism of self-tolerance J. Exp. Med. 172 6 1990 1735 1739
163. F. Novelli, M.M. D'Elios, P. Bernabei, L. Ozmen, L. Rigamonti, F. Almerigogna, and et al. Expression and role in apoptosis of the alpha- and beta-chains of the IFN-gamma receptor on human Th1 and Th2 clones J. Immunol. 159 1 1997 206 213
164. G.A. Bishop, B.M. Hall, M.G. Suranyi, D.T. Tiller, J.S. Horvath, and G.G. Duggin Expression of HLA antigens on renal tubular cells in culture: 1. Evidence that mixed lymphocyte culture supernatants and gamma interferon increase both class I and class II HLA antigens Transplantation 42 1986 671 679
165. B.M. Hall, G.A. Bishop, G.G. Duggin, J.S. Horvath, J. Philips, and D.J. Tiller Increased expression of HLA-DR antigens on renal tubular cells in renal transplants: relevance to the rejection response Lancet 2 8397 1984 247 251
166. Y. Takei, T.N. Sims, J. Urmson, and P.F. Halloran Central role for interferon-gamma receptor in the regulation of renal MHC expression J. Am. Soc. Nephrol. 11 2 2000 250 261
167. S.M. Coley, M.L. Ford, S.C. Hann, M.E. Wagener, A.D. Kirk, and C.P. Larsen IFN-g dictates allograft fate via opposing effects on the graft and recipient CD8T cell responses J. Immunol. 182 2008 225 233
168. B. Sis, K.S. Famulski, K.L. Allanach, L.-F. Zhu, and P.F. Halloran IFN-g prevents early perforin-granzyme-mediated destruction of kidney allografts by inducing donor class I products in the kidney Am. J. Transplant. 7 2007 2301 2310
169. P.F. Halloran, M. Afrouzian, V. Ramassar, J. Urmson, L.F. Zhu, L.M. Helms, and et al. Interferon-gamma acts directly on rejecting renal allografts to prevent graft necrosis Am. J. Pathol. 158 1 2001 215 226
170. P.F. Halloran, L.W. Miller, J. Urmson, V. Ramassar, L.F. Zhu, N.M. Kneteman, and et al. IFN-gamma alters the pathology of graft rejection: protection from early necrosis J. Immunol. 166 12 2001 7072 7081
171. M. Afrouzian, V. Ramassar, J. Urmson, L.F. Zhu, and P.F. Halloran Transcription factor IRF-1 in kidney transplants mediates resistance to graft necrosis during rejection J. Am. Soc. Nephrol. 13 5 2002 1199 1209
172. M.M. Mazanet, and C.C. Hughes B7-H1 is expressed by human endothelial cells and suppresses T cell cytokine synthesis J. Immunol. 169 7 2002 3581 3588
173. N. Rodig, T. Ryan, J.A. Allen, H. Pang, N. Grabie, T. Chernova, and et al. Endothelial expression of PD-L1 and PD-L2 down-regulates CD8 + T cell activation and cytolysis Eur. J. Immunol. 33 11 2003 3117 3126
174. D.O. Willenborg, M.A. Staykova, and W.B. Cowden Our shifting understanding of the role of nitric oxide in autoimmune encephalomyelitis: a review J. Neuroimmunol. 100 1-2 1999 21 35
175. C. Wang, S.S. Tay, G.T. Tran, S.J. Hodgkinson, R.D. Allen, B.M. Hall, and et al. Donor IL-4-treatment induces alternatively activated liver macrophages and IDO-expressing NK cells and promotes rat liver allograft acceptance Transpl. Immunol. 22 3-4 2010 172 178
176. A.O. Hall, J.S. Silver, and C.A. Hunter The Immunobiology of IL-27 Adv. Immunol. 115 2012 1 44
177. M. Batten, N.M. Kljavin, J. Li, M.J. Walter, F.J. de Sauvage, and N. Ghilardi Cutting edge: IL-27 is a potent inducer of IL-10 but not Foxp3 in murine cells J. Immunol. 180 2008 2752 2756
178. G. Murugaiyan, A. Mittal, R. Lopez-Diego, L.M. Maier, D.E. Anderson, and H.L. Weiner IL-27 is a key regulator of IL-10 and IL-17 production by human Cd4 + T cells J. Immunol. 183 2009 2435 2443
179. A. Villarino, L. Hibbert, L. Lieberman, E. Wilson, T. Mak, H. Yoshida, and et al. The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection Immunity 19 2003 645 655
180. A. Villarino, J.R. Larkin, C.J. Saris, A.J. Caton, S. Lucas, T. Wong, and et al. Positive and negative regulation of the IL-27 receptor during lymphoid activation J. Immunol. 174 2005
181. S.J. Moon, J.S. Park, Y.J. Heo, C.M. Kang, E.K. Kim, M.A. Lim, and et al. In vivo action of IL-27: reciprocal regulation of Th17 and Treg cells in collagen-induced arthritis Exp. Mol. Med. 45 2013 e46
182. L. Le Texier, P. Thebault, M. Carvalho-Gaspar, V. Vignard, E. Merieau, C. Usal, and et al. Immunoregulatory function of IL-27 and TGF-β1 in cardiac allograft transplantation Transplantation 15 3 2012 226 233
183. D. Sekar, C. Hahn, B. Brüne, E. Roberts, and A. Weigert Apoptotic tumor cells induce IL-27 release from human DCs to activate Treg cells that express CD69 and attenuate cytotoxicity Eur. J. Immunol. 42 6 2012 1585 1598
184. S.F. Häusler, I. Montalbán Del Barrio, J. Strohschein, P. Anoop Chandran, J.B. Engel, A. Hönig, and et al. Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity Cancer Immunol. Immunother. 60 Jun 3 2011 1405 1418
185. E.D. Wojno, N. Hosken, J.S. Stumhofer, A.C. O'Hara, E. Mauldin, Q. Fang, and et al. A role for IL-27 in limiting T regulatory cell populations J. Immunol. 187 1 2011 266 273
186. J.Q. Liu, Z. Liu, X. Zhang, Y. Shi, F. Talebian, J.W. Carl Jr., and et al. Increased Th17 and regulatory T cell responses in EBV-induced gene 3-deficient mice lead to marginally enhanced development of autoimmune encephalomyelitis J. Immunol. 188 7 2012 3099 3106
187. I. Kochetkova, S. Golden, K. Holderness, G. Callis, and D.W. Pascual IL-35 stimulation of CD39 + regulatory T cells confers protection against collagen II-induced arthritis via the production of IL-10 J. Immunol. 184 12 2010 7144 7153
188. M. Huber, V. Steinwald, A. Guralnik, A. Brustle, P. Kleemann, C. Rosenplanter, and et al. IL-27 inhibits the development of regulatory T cells via STAT3 Int. Immunol. 20 2 2008 223 234
189. C. Neufert, C. Becker, S. Wirtz, M.C. Fantini, B. Weigmann, P.R. Galle, and et al. IL-27 controls the development of inducible regulatory T cells and Th17 cells via differential effects on STAT1 Eur. J. Immunol. 37 7 2007 1809 1816
190. C. Holscher, A. Holscher, T. Yoshimoto, H. Yoshida, T. Mak, C. Saris, and et al. The IL-27 receptor chain WSX-1 differentially regulates antibacterial immunity and survival during experimental tuberculosis 1 J. Immunol. 174 2005 3534 3544
191. R. Schneider, T. Yaneva, D. Beauseigle, L. El-Khoury, and N. Arbour IL-27 increases proliferation and effector functions of human naive CD8 + T lymphocytes and promotes their development into Tc1 cells Eur. J. Immunol. 41 2011 47 59
192. G.T. Tran, N. Carter, X.Y. He, T.S. Spicer, K.M. Plain, M. Nicolls, and et al. Reversal of experimental allergic encephalomyelitis with non-mitogenic, non-depleting anti-CD3 mAb therapy with a preferential effect on T(h)1 cells that is augmented by IL-4 Int. Immunol. 13 9 2001 1109 1120
193. X.Y. He, J. Chen, N. Verma, K. Plain, G. Tran, and B.M. Hall Treatment with interleukin-4 prolongs allogeneic neonatal heart graft survival by inducing T helper 2 responses Transplantation 65 9 1998 1145 1152
194. S.T. Spicer, H. Ha, R.A. Boyd, X.Y. He, N. Carter, G. Tran, and et al. IL-4 therapy prevents the development of proteinuria in Active Heymann Nephritis by inhibition of Tc1 cells J. Immunol. 167 7 2001 3725 3733
195. C. Wang, J. Li, S.P. Cordoba, D.J. McLeod, G.T. Tran, S.J. Hodgkinson, and et al. Posttransplant interleukin-4 treatment converts rat liver allograft tolerance to rejection Transplantation 79 9 2005 1116 1120
196. X.Y. He, N. Verma, J. Chen, C. Robinson, R. Boyd, and B.M. Hall IL-5 prolongs allograft survival by downregulating IL-2 and IFN-gamma cytokines Transplant. Proc. 33 1-2 2001 703 704
197. K.P. Walsh, M.T. Brady, C.M. Finlay, L. Boon, and K.H. Mills Infection with a helminth parasite attenuates autoimmunity through TGF-beta-mediated suppression of Th17 and Th1 responses J. Immunol. 183 2009 1577 1586
198. C.E. Tadokoro, A.L. Vallochi, L.S. Rios, G.A. Martins, D. Schlesinger, T. Mosca, and et al. Experimental autoimmune encephalomyelitis can be prevented and cured by infection with Trypanosoma cruzi J. Autoimmun. 23 2004 103 115
199. D.L. Ledingham, V. McAlister, H.N. Ehigiator, C. Giacomantonio, M. Theal, and T.D. Lee Prolongation of allograft survival by nematodes Transplantation 61 1996 184 189
200. R. Liwiski, J. Zhou, V. McAlister, and T.D. Lee Prolongation of allograft survival by Nippostrongylus brasiliens is associated with decreased allospecific cytotoxic T lymphocyte activity and development of T cytotoxic type 2 cells Transplantation 69 2000 1912 1918
201. J. Correale, and M. Farez Association between parasite infection and immune responses in multiple sclerosis Ann. Neurol. 61 2 2007 97 108
202. B.M. Hall Transplantation tolerance: a 1988 perspective Transplant. Proc. 21 1 Pt 1 1989 816 819
203. S. Qin, S.P. Cobbold, H. Pope, J. Elliott, D. Kioussis, J. Davies, and et al. "Infectious" transplantation tolerance Science 259 1993 974 977
204. S. Sakaguchi, N. Sakaguchi, M. Asano, M. Itoh, and M. Toda Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases J. Immunol. 155 3 1995 1151 1164
205. I. Apostolou, and H. von Boemer In vivo instruction of suppressor commitment in naive T cells J. Exp. Med. 199 2004 1401 1408
206. S.P. Cobbold, R. Castejon, E. Adams, D. Zelenika, L. Graca, S. Humm, and et al. Induction of foxP3 + regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants J. Immunol. 172 10 2004 6003 6010
207. M.A. Curotto de Lafaille, A.C. Lino, N. Kutchukhidze, and J.J. Lafaille CD25- T cells generate CD25 + Foxp3 + regulatory T cells by peripheral expansion J. Immunol. 173 12 2004 7259 7268
208. S. Liang, P. Alard, Y. Zhao, S. Parnell, S.L. Clark, and M.M. Kosiewicz Conversion of CD4 + CD25- cells into CD4 + CD25 + regulatory T cells in vivo requires B7 costimulation, but not the thymus J. Exp. Med. 201 1 2005 127 137
209. B. Knoechel, J. Lohr, E. Kahn, J.A. Bluestone, and A.K. Abbas Sequential development of interleukin 2-dependent effector and regulatory T cells in response to endogenous systemic antigen J. Exp. Med. 202 2005 1375 1386
210. U. Baron, S. Floess, G. Wieczorek, K. Baumann, A. Grützkau, J. Dong, and et al. DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells Eur. J. Immunol. 37 2007 2378 2389
211. S. Hori, T. Nomura, and S. Sakaguchi Control of regulatory T cell development by the transcription factor Foxp3 Science 299 5609 2003 1057 1061
212. L. Graca, S.P. Cobbold, and H. Waldmann Identification of regulatory T cells in tolerated allografts J. Exp. Med. 195 12 2002 1641 1646
213. P.A. Taylor, C.J. Lees, and B.R. Blazar The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality Blood 99 10 2002 3493 3499
214. P.A. Taylor, A. Panoskaltsis-Mortari, J.M. Swedin, P.J. Lucas, R.E. Gress, B.L. Levine, and et al. l-selectin(hi) but not the l-selectin(lo) CD4 + 25 + T-regulatory cells are potent inhibitors of GVHD and BM graft rejection Blood 104 12 2004 3804 3812
215. E. Nishimura, T. Sakihama, R. Setoguchi, K. Tanaka, and S. Sakaguchi Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3 + CD25 + CD4 + regulatory T cells Int. Immunol. 16 8 2004 1189 1201
216. M. Hara, C.I. Kingsley, M. Niimi, S. Read, S.E. Turvey, A.R. Bushell, and et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo J. Immunol. 166 6 2001 3789 3796
217. C.I. Kingsley, M. Karim, A.R. Bushell, and K.J. Wood CD25 + CD4 + regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses J. Immunol. 168 3 2002 1080 1086